Nalaganje...
Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies
Triple negative breast cancer (TNBC) has high metastatic and mortality potential and lacks effective and selective therapeutic options. Aberrant dysregulation of the receptor tyrosine kinase c-Met promotes TNBC progression, motility and survival and therefore considered a valid therapeutic target. A...
Shranjeno v:
| izdano v: | Nutr Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193555/ https://ncbi.nlm.nih.gov/pubmed/29083228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2017.1367936 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|